Owner Janssen Pharmaceutica, N.V.

Inventors Pan, Meng; Xia, Mingde; Wachter, Michael P.; Liotta, Fina; Lagu, Bharat

Agent Shelston IP

Pub. Number AU-B-2005228868

PCT Pub. Number WO2005/095353

Priority 60/555,890 24.03.04 US

Filing date 23 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 9 February 2012

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids